Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Clostridium Difficile Infection Recurrence: full-pipeline trial registry
2 of 3 indexed Clostridium Difficile Infection Recurrence trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Clostridium Difficile Infection Recurrence: 3 US clinical trials tracked, 2 recruiting.
Clostridium Difficile Infection Recurrence is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Finch Research and Development, running 1 of these trials.
Enrollment posture brief
Registry condition clostridium-difficile-infection-recurrence
OPEN 2 | RECR 67% | LATE 1 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Clostridium Difficile Infection Recurrence lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Clostridium Difficile Infection Recurrence on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Clostridium Difficile Infection Recurrence is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Vedanta Biosciences
NCT06237452
Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
Krunal Patel
NCT03562741
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff
Finch Research and Development
NCT03110133
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Clostridium Difficile Infection Recurrence records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Clostridium Difficile Infection Recurrence trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Clostridium Difficile Infection Recurrence page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Clostridium Difficile Infection Recurrence trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Finch Research and Development sponsors the most Clostridium Difficile Infection Recurrence trials on record, review their full trial history before evaluating a specific study. See Finch Research and Development's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Clostridium Difficile Infection Recurrence condition card totals 3 registered trials; most-linked intervention Full Spectrum Microbiota; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.